APA (7th ed.) Citation

E, A., K, K., & Y, W. (2026). Outcomes of minimally invasive conversion surgery after immune checkpoint inhibitors for stage IV gastric cancer. Surgical oncology, 66, 102429. https://doi.org/10.1016/j.suronc.2026.102429

Chicago Style (17th ed.) Citation

E, Amada, Kumagai K, and Watanabe Y. "Outcomes of Minimally Invasive Conversion Surgery After Immune Checkpoint Inhibitors for Stage IV Gastric Cancer." Surgical Oncology 66 (2026): 102429. https://doi.org/10.1016/j.suronc.2026.102429.

MLA (9th ed.) Citation

E, Amada, et al. "Outcomes of Minimally Invasive Conversion Surgery After Immune Checkpoint Inhibitors for Stage IV Gastric Cancer." Surgical Oncology, vol. 66, 2026, p. 102429, https://doi.org/10.1016/j.suronc.2026.102429.